06:37:56 EST Thu 22 Jan 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Herbal Dispatch Inc. - Common Shares
Symbol HERB
Shares Issued 123,344,919
Close 2026-01-21 C$ 0.08
Market Cap C$ 9,867,594
Recent Sedar+ Documents

ORIGINAL: Herbal Dispatch Announces 298kg Export Destined for German Market

2026-01-22 03:37 ET - News Release

Vancouver, British Columbia--(Newsfile Corp. - January 22, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCID: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company") a leading cannabis e-commerce and distribution platform, is pleased to announce that it has completed a 298kg export of medical cannabis that is destined for the German medical cannabis market. The export was exported through Portugal to a new export relationship that is expected to provide strong revenue opportunities for the Company in 2026 and beyond.

This marks the Company's inaugural shipment of medical cannabis to this European Union Good Manufacturing Practices (EU-GMP) licensed processor in Portugal. The Company anticipates multiple follow-on exports to this partner in the coming quarters. Following EU-GMP compliant processing in Portugal, the product is destined for Germany-the European Union's largest and most dynamic medical cannabis market, which saw record imports exceeding 140 tonnes in the first nine months of 2025 alone (with Q3 2025 reaching nearly 57 tonnes), driven by surging patient demand and an increased annual import quota to approximately 192.5 tonnes.

Germany continues to lead Europe's medical cannabis sector, with rapid patient growth, record import volumes, and projected market expansion significantly in 2025-2026, driven by increasing demand for high-quality, compliant products. This strategic partnership positions Herbal Dispatch to capitalize on Germany's position as the EU's premier market for medical cannabis, offering substantial long-term growth potential through recurring exports and strengthened European supply chain access.

"We are thrilled to achieve this milestone with our first export to our Portuguese partner, marking a key step in expanding our international footprint," said Philip Campbell, CEO of Herbal Dispatch. "Germany represents the most dynamic and largest medical cannabis opportunity in Europe, and we are excited about the future potential this new relationship unlocks. By leveraging euGMP processing in Portugal to supply this high-demand market, we anticipate building a robust, recurring revenue stream that will drive meaningful growth for the Company and deliver value to our shareholders in 2026 and beyond."

ABOUT HERBAL DISPATCH INC.

Herbal Dispatch Inc. (CSE: HERB) owns and operates leading cannabis e-commerce platforms in Canada, dedicated to providing top-quality cannabis and related products to informed consumers at affordable prices. The Company's flagship marketplace offers exclusive access to small-batch craft cannabis and a wide array of other products.For more information, please visit www.herbaldispatch.com or contact:

Investor Relations

Email: philip@herbaldispatch.com

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

Certain statements in this news release, including statements or information containing terminology such as "anticipate", "believe", "intend", "expect", "estimate", "may", "could", "will", and similar expressions constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, that address activities, events, or developments that the Company or a third party expect or anticipate will or may occur in the future, including the Company's future growth, results of operations, performance, and business prospects and opportunities are forward-looking statements. These forward-looking statements reflect the Company's current beliefs and are based on information currently available to the Company. These statements require the Company to make assumptions it believes are reasonable and are subject to inherent risks and uncertainties.

Actual results and developments may differ materially from the anticipated results and developments discussed in the forward-looking statements as certain of these risks and uncertainties are beyond the Company's control. These risk factors are interdependent and the impact of any one risk or uncertainty on a particular forward-looking statement is not determinable. Examples of forward-looking statements in this news release and the key assumptions and risk factors involved in such statements include, but are not limited to, the retention of key individuals to promote the success of the Company's business, as well as market and investor participation. The successful execution of these initiatives is subject to a number of risks and uncertainties, including industry competition, and future customer demand for the Company's products, among others. Consequently, all of the forward-looking statements made in this news release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected effects on the Company. These forwardlooking statements are made as of the date of this news release. Except as required by applicable securities legislation, the Company assumes no obligation to update publicly or revise any forward-looking statements to reflect subsequent information, events, or circumstances.

THE CANADIAN SECURITIES EXCHANGE (THE "CSE") HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS NEWS RELEASE. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/281235

© 2026 Canjex Publishing Ltd. All rights reserved.